4.7 Review

The structure and function of the S1P1 receptor

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 34, Issue 7, Pages 401-412

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2013.05.002

Keywords

sphingosine 1-phosphate receptor; receptor structure; fingolimod; FTY720; multiple sclerosis

Funding

  1. Trinity College Dublin
  2. Health Research Board Ireland
  3. Science Foundation Ireland
  4. Higher Education Authority Ireland (Programme for Research in Third Level Institutions [PRTLI])

Ask authors/readers for more resources

Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs). S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems. The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity. Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clinical use. Much progress has also recently been made in the field of structural biology and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined. Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein-protein interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available